Literature DB >> 2370134

"Hemicrania episodica"--a new type of headache or a pre-chronic stage of hemicrania continua?

J A Pareja1, T Palomo, M A Gorriti, J Pareja, J Espejo.   

Abstract

For seventeen years, a young man suffered from headaches of one to three days duration occurring once every six or seven days and totally disappearing between episodes. These were strictly unilateral (always on the left side), and were absolutely responsive to indomethacin. They differ clinically from the other two indomethacin-responsive headaches described up to now: Hemicrania Continua (HC) and Chronic Paroxysmal Hemicrania (CPH). He has a sister suffering from HC. Similar to HC, but unlike CPH, topical tyramine in our patient's eyes resulted in anisocoria before, but not after, indomethacin treatment. Our case differs from HC, however, in its time pattern; it could either be a pre-chronic stage of HC or a new type of headache. It seems unlikely that a time pattern that has remained unchanged for 17 years will become continuous, as in HC, in the future, and thus it is possible that our patient represents a case of a new type of headache that we propose to name "Hemicrania Episodica." In any case, it seems probable that this type of headache, although clinically different, may share a common pathogenic basis with HC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370134     DOI: 10.1111/j.1526-4610.1990.hed3006344.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Hemicrania continua in African Americans.

Authors:  Steve D Wheeler
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

Review 2.  Hemicrania continua: recent treatment strategies and diagnostic evaluation.

Authors:  Mario F P Peres
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

Review 3.  Update on hemicrania continua.

Authors:  Elisabetta Cittadini; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2011-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.